Selank: Patient Information & Safety Notes
Also known as TP-7, Selanc
Other names: tp-7, selanc
Selank is a synthetic heptapeptide analogue of tuftsin developed in Russia. It has been studied in Russian clinical trials for anxiety and cognitive enhancement. It has anxiolytic effects without sedation in limited studies. It is NOT FDA-approved in the United States.
In plain language
What Selank is used for
- Investigated for anxiety reduction, cognitive support, and stress resilience (primarily Russian studies)
Taking this medicine
How it is administered
- Intranasal spray
Read before you decide
Risks and precautions
Risks and warnings
- Mild nasal irritation
- Headache, fatigue
- Occasional sleep disturbances
Who should not take it
- Pregnancy
Common questions
Patient questions
Is selank an approved anxiolytic?
Not in the United States. Selank is approved in Russia for some indications. US FDA approval has not been sought or granted. Individuals with anxiety should discuss FDA-approved treatments with a licensed provider.
Related medications
Explore treatment hubs
This information is educational — not medical advice.
This page is provided for general educational purposes and summarizes publicly available data from sources such as the U.S. Food & Drug Administration. It is not a substitute for the judgment of a licensed clinician and should not be used to start, stop, or change any medication. It may be incomplete or out of date, and individual circumstances vary. Always talk with your prescriber or pharmacist about your specific medications and health conditions. If you think you may have a medical emergency, call 911.
Sources & References
Learn more about where our data comes from and how we write and review medical content.